Want to track 4503 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Astellas Pharma Inc (4503) Statistics
Valuation metrics
Market Cap 3.53T
Enterprise value 4.12T
Trailing P/E (ttm) 13.18
Forward P/E 30.29
PEG ratio 0.03
Price/Sales (ttm) 1.79
Price/Book (mrq) 2.1
Enterprise Value/Revenue 1.93
Enterprise Value/EBITDA 6.64
Overview
Shares outstanding 1.79B
Float 1.79B
Shares short -
% Held by insiders 0%
% Held by institutions 0.57%
Average volume (10 days) 6.45M
Average volume (90 days) 5.91M
Price summary
52-Week low 1,343.5
52-Week high 2,717
Beta 0.08
50-Day moving average 2,246.41
200-Day moving average 2,302.38
Dividends and splits
Forward annual dividend rate 78
Forward annual dividend yield 0.0344%
Trailing annual dividend rate 78
Trailing annual dividend yield 0.0364%
5-Year annual dividend yield 3.46%
Payout ratio 0.47
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 5:1
Last split Date 27 Mar 2014
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.14%
Operating margin 0.19%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.17%
Income Statement
Revenue (ttm) 2.14T
Revenue per share (ttm) 1,191.26
Quarterly revenue growth (yoy) 0.21%
Gross profit (ttm) 1.73T
EBITDA 247B
Net income to common (ttm) 291.53B
Diluted EPS (ttm) 162.37
Quarterly earnings growth (yoy) -0.04%
Balance Sheet
Total cash (mrq) 281.61B
Total cash per share (mrq) 156.81
Total debt (mrq) 565.95B
Total Debt/Equity (mrq) 0.31
Current ratio (mrq) 1.17%
Book value per share (mrq) 1,019.55
Cash Flow
Cash flow statement 560.19B
Levered free cash flow (LFCF) 388.72B
